Life ScienceCompany
Where is Inositec headquartered?
Inositec is headquartered in Zurich, Switzerland.
What sector is Inositec in?
Inositec is a life science company.
When was Inositec founded?
Inositec was founded in 2015.
Inositec is headquartered in Zurich, Switzerland.
Inositec is a life science company.
Inositec was founded in 2015.
Technoparkstrasse 1,
Zurich,
8005
Switzerland,
+41 44 271 07 55
www.inositec.com
Inositec is developing first-in-class treatments for soft tissue calcification disorders based on its proprietary Inositune platform of inositol phosphate (IP6) analogs. The company’s lead programs address vascular and renal calcification disorders, including orphan indications. Inositec’s novel asset INS-3001, is a once-daily subcutaneous treatment for patients with vascular calcification disorders PAD and AVS, which are both major contributors to cardiovascular morbidity and mortality in affected patient populations. With INS-3001 daily subcutaneous dosing, patients with earlier stages of vascular calcification can be optimally treated, while end-stage kidney disease patients will benefit from the three times per week dosing regimen of SNF472. Inositec was formed in 2015 and is based in Zurich, Switzerland.
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
